Mattei, A., Schiavoni, L., Riva, E., Ciccozzi, M., Veralli, R., Urselli, A., . . . Carassiti, M. (2024). Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19. Intensive Care Medicine Experimental, 12(1), 1. https://doi.org/10.1186/s40635-024-00624-9
Chicago Style (17th ed.) CitationMattei, Alessia, et al. "Epstein–Barr Virus, Cytomegalovirus, and Herpes Simplex-1/2 Reactivations in Critically Ill Patients with COVID-19." Intensive Care Medicine Experimental 12, no. 1 (2024): 1. https://doi.org/10.1186/s40635-024-00624-9.
MLA (9th ed.) CitationMattei, Alessia, et al. "Epstein–Barr Virus, Cytomegalovirus, and Herpes Simplex-1/2 Reactivations in Critically Ill Patients with COVID-19." Intensive Care Medicine Experimental, vol. 12, no. 1, 2024, p. 1, https://doi.org/10.1186/s40635-024-00624-9.